Tag: diabetes mellitus type 2

Omega-3, Vit-D Both Fail at AF Primary Prevention in VITAL-Rhythm

Clinical trials of omega-3 fatty acid or vitamin D supplements have followed a long and winding road in search of benefits in cardiovascular (CV) disease,...

Lancet Panel Calls for Urgent Global Action to Combat Diabetes

A panel convened by The Lancet has published a comprehensive report calling for major initiatives to improve diabetes prevention and care around the world.  ...

Data Contradict on Statin Effect in Diabetes With COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two observational studies have yielded opposite findings regarding the effect of...

Diabetes Screening Program in Optometry Offices to Expand

A program in which optometrists conduct in-office diabetes screening is now being expanded based on successful pilot data. The program is sponsored by VSP Vision...

Novel Drug Slows Progression of Diabetic Kidney Disease

For patients with diabetic kidney disease, finerenone, an agent from a new class of selective, nonsteroidal mineralocorticoid receptor antagonists, led to significant reductions in combined...

US FDA Advises Against Dispensing Single Insulin Pens

The US Food and Drug Administration (FDA) is advising clinicians to dispense insulin pens in their original sealed cartons to a single diabetes patient.  FDA...

Substance in Tears Could Be Used for Diabetes Monitoring

Dr Masakazu Aihara Measuring glycated albumin (glycoalbumin, GA) in tears could be a future way for those with diabetes to monitor their blood sugar levels...

Vericiguat Benefits Even With High Adherence to HFrEF Meds

Vericiguat (Merck/Bayer), among the latest drugs to gain cred in heart failure (HF) with reduced ejection fraction (HFrEF), significantly benefits patients who are highly adherent...

Weight Loss in Obesity May Stall Neuropathy Progress

Among obese people with polyneuropathy, significant weight loss appears to halt progression of the painful condition while improving some key measures, a new study suggests....

Emerging Data on Diabetes and COVID-19 Reassuring

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Most people with type 1 diabetes do not appear to be...

PPIs Associated With Diabetes Risk, but Questions Remain

Regular use of proton pump inhibitors (PPIs) is associated with an increased risk of type 2 diabetes, according to a large prospective analysis of the...

Metformin Linked to Reduced Cognitive Decline, Dementia Risk

Older people taking metformin, the first-line treatment for type 2 diabetes, show significantly lower rates of dementia and cognitive decline compared to those with diabetes...

Higher ‘Time in Range’ May Benefit Type 2 Diabetes Patients

Patients with type 2 or type 1 diabetes who stay in a blood glucose range of 70-180 mg/dL at least 70% of the time have...

British Protocol Allows Insulin-Treated Pilots to Fly Safely

A protocol developed in the UK that allows commercial pilots with insulin-treated diabetes to fly airplanes has resulted in precise glycemic control during flight and...

Hepatocellular Carcinoma Shows Risk Factor Shift

Rates of hepatocellular carcinoma (HCC) continue to rise in the United States, but unevenly so given how the incidence has become highest in the Hispanic...

Ertugliflozin Benefit Falls Short of Other SGLT2 Inhibitors

Further analyses from the cardiovascular outcome trial of the sodium-glucose transporter 2 inhibitor ertugliflozin in patients with type 2 diabetes helped better define positive effects...

Even Moderate Drinking May Raise Hypertension Risk in Diabetes

New research suggests that even moderate alcohol consumption may raise hypertension risk in adults with type 2 diabetes (T2D). Investigators analyzed data from over 10,000...

Novel Type 2 Diabetes Drugs Incur High Costs in Medicare

Switching Medicare beneficiaries who have type 2 diabetes to one of the novel glucose-lowering medications could dramatically raise their out-of-pocket costs, thereby potentially hindering adherence,...

‘Dose-Response’ Between Exercise and Improvement in Diabetes

The more patients with type 2 diabetes exercise, the greater their drop in A1c, according to a new post-hoc analysis of data collected during 6...

Reassuring Findings on SSRIs and Diabetes Risk in Kids

Selective serotonin reuptake inhibitors are associated with a much lower risk of type 2 diabetes (T2D) in children and adolescents than previously reported, new research...

Nine US States Cap Insulin Cost, but Activists Will ‘Fight Harder’

Nine US states have passed laws aimed at making insulin more affordable — and more than 30 are considering such legislation — but they all...

Gut Bacteria Linked to Cardiovascular, Other Health Conditions

Microorganisms in the human digestive tract are linked to 29 specific health conditions, including chronic obstructive pulmonary disease, high blood pressure, and type 2 diabetes,...

SGLT2 Inhibitor Benefits CKD Without Diabetes

Add patients with chronic kidney disease with or without diabetes to the growing list of people who get proven benefit from treatment with an SGLT2...

Blacks With Diabetes Lose Limbs at 3x the Rate of Others

Prompted by a ProPublica story that detailed how Black Americans with diabetes lose limbs at a rate triple that of others, the American Diabetes Association...

Empagliflozin’s HFrEF Benefit Solidifies Class Effects

The SGLT2 inhibitor drug class solidified its role as a major, new treatment for patients who have heart failure with reduced ejection fraction and no...